NuScale's 84% Plunge: No Change in Fundamental Risks

What happened

NuScale Power stock has fallen 84% from its 52-week high, but the deep-value analysis shows the company's pre-commercial standing remains unchanged. The only binding milestone—NRC design approval—is already priced in, while cash burn, dilution via a $1.0B ATM program, and a non-binding TVA-ENTRA1 pathway continue to dominate the risk profile. Despite the tempting dip, auditable SEC filings confirm no binding contract for NPM delivery, no PMA Milestone 2 accrual, and a $314.7M operating cash outflow last quarter. The market narrative of a 'nuclear renaissance' collides with these hard financial realities, making the stock a high-risk speculative bet rather than a value opportunity.

Implication

Investors should wait for verifiable SEC signals of commercialization—a binding PPA or NuScale revenue contract—before considering any position. Until then, asymmetric downside from dilution and cash burn outweighs the upside optionality.

Thesis delta

No material shift: the bullish hope that the stock's decline has priced in the risks is not supported by filings. The key catalysts remain unchanged—binding contracts at TVA-ENTRA1 or Romania—and have not yet materialized. The thesis retains a bearish tilt, with the potential for further downside if cash burn continues and dilution accelerates.